Vor Biopharma Inc (NASDAQ: VOR) – Suitable For Long Term Buy?
Currently, there are 124.85M common shares owned by the public and among those 76.86M shares have been available to trade. The company’s stock has a 5-day price change of 30.89% and 332.53% over the past three months. VOR shares are trading 174.66% year to date (YTD), with the 12-month market performance up to 125.23% higher. […]
Analyst Expect Big Moves From Vor Biopharma Inc (NASDAQ: VOR)
Currently, there are 124.85M common shares owned by the public and among those 76.86M shares have been available to trade. The company’s stock has a 5-day price change of 114.61% and 201.26% over the past three months. VOR shares are trading 93.07% year to date (YTD), with the 12-month market performance up to 72.07% higher. […]
Gains May Be On The Menu For Vor Biopharma Inc (NASDAQ: VOR)
Currently, there are 124.85M common shares owned by the public and among those 76.86M shares have been available to trade. The company’s stock has a 5-day price change of 341.12% and 38.42% over the past three months. VOR shares are trading -14.52% year to date (YTD), with the 12-month market performance down to -4.50% lower. […]
Vor Biopharma Inc (NASDAQ: VOR) – Suitable For Long Term Buy?
Currently, there are 124.85M common shares owned by the public and among those 76.86M shares have been available to trade. The company’s stock has a 5-day price change of 59.25% and -66.67% over the past three months. VOR shares are trading -75.83% year to date (YTD), with the 12-month market performance down to -73.87% lower. […]
Vor Biopharma Inc (NASDAQ: VOR): Stock That Needs Special Handling
Currently, there are 124.85M common shares owned by the public and among those 76.86M shares have been available to trade. The company’s stock has a 5-day price change of 16.92% and -87.09% over the past three months. VOR shares are trading -84.06% year to date (YTD), with the 12-month market performance down to -89.47% lower. […]